#To See The Beauty Of Life
Luxottica to begin financial reporting in accordance with IAS/IFRS
Luxottica Group S.p.A. (MTA: LUX; NYSE: LUX) announced today that starting with the first quarter of fiscal year 2010 and for all future reporting periods it will report its financial results in accordance with the International Accounting and Reporting Standards (“IAS/IFRS”) in all financial communications including reports to the Securities and Exchange Commission of the United States (“SEC”). Up to and including the 2009 fiscal year, Luxottica had been reporting its financial results under Generally Accepted Accounting Principles of the United States (“U.S. GAAP”), which it used since its initial listing on the New York Stock Exchange.
The requirements of IAS/IFRS and U.S. GAAP have converged in recent years, which has facilitated Luxottica’s transition to a single set of accounting standards for all of its external reporting. In addition, since 2007, the SEC has allowed foreign issuers to file their financial statements prepared in accordance with IFRS without requiring any reconciliation to U.S. GAAP.
Since 2005, the Group has also been preparing consolidated financial statements in Italy in accordance with IAS/IFRS as required by Italian laws, and has provided the financial community with a reconciliation of its U.S. GAAP and IAS/IFRS results on a quarterly basis.
Based on our recent results, the principal differences between U.S. GAAP and IFRS as they relate to Luxottica are immaterial from a financial perspective and include:
- Share-based payment (IFRS 2 vs ASC 718) and related tax effects (IAS 12 vs ASC 740):
- The method for the recognition of share-based payments charges upon a change in the vesting period (service period in which the employees provide their services in exchange for share-based payments), which is prospective under U.S. GAAP and retrospective under IAS/IFRS.
- The method to calculate the tax effects associated with stock option expensing: under U.S. GAAP, the tax effect is calculated based on the fair value of the options as of the grant date and under IAS/IFRS, the calculation is based on the intrinsic value of the stock options (difference between exercise price and share price as of the balance sheet date).
- Inventories (IAS 2 vs ASC 330): certain types of costs can be capitalized under IAS/IFRS but not under U.S. GAAP.
- Business combinations (IFRS 3 vs ASC 805): differences in 2009 (year in which the Group utilized the old IFRS 3 version) included:
- certain ancillary acquisition costs which could be capitalized under old IFRS 3, applied to the Group until December 31, 2009, but not under ASC 805. With the revised IFRS 3, which took effect on January 1, 2010, the capitalization of such costs is no longer permitted;
- the recognition of business combinations in which non-controlling shareholders are granted a put option to sell their interest to the Group. Under IAS/IFRS, companies acquired and accounted for under this formula are fully consolidated without a separate line item for non-controlling interests. Under U.S. GAAP, such subsidiaries are consolidated in proportion to the Group’s ownership, with a separate line item indicating the equity and profit pertaining to non-controlling interests.
- Employee Benefits (IAS 19 vs ASC 715): Under U.S. GAAP, the time horizon to calculate expected returns on plan assets may be based on the fair value of the assets over a period as long as 5 years. Under IAS/IFRS, this calculation is performed on the fair value of the assets as of the balance sheet date.
- Long-Term debt (IAS 39 vs ASC 310): U.S. GAAP permits the capitalization of borrowing costs and their amortization over the life of the loan. Under IAS/IFRS, such costs are recognized on the basis of their amortized costs, calculated on the basis of the effective interest rate.
The financial statements for the quarter ended March 31, 2010, which will be reviewed and approved by the Board of Directors on April 29, 2010, will be reported in accordance with IAS/IFRS. For a comparison with the results published in 2009 (in accordance to U.S. GAAP), the financial statements of the Group, which were already published in 2009 on a quarterly basis, and its divisions are shown below as prepared in accordance with IAS/IFRS. Such figures will be used as a comparative base for the 2010 financial statements. In 2010 the company will not report an IAS/IFRS to U.S. GAAP reconciliation
About Luxottica Group S.p.A.
Luxottica Group is a leader in premium fashion, luxury and sports eyewear, with over 6,200 optical and sun retail stores in North America, Asia-Pacific, China, South Africa and Europe and a strong and well-balanced brand portfolio. Luxottica’s key house brands include Ray-Ban, the best known sun eyewear brand in the world, Oakley, Vogue, Persol, Oliver Peoples, Arnette and REVO, while license brands include Bvlgari, Burberry, Chanel, Dolce & Gabbana, Donna Karan, Polo Ralph Lauren, Prada, Salvatore Ferragamo, Tiffany and Versace. In addition to a global wholesale network covering 130 countries, the Group manages leading retail brands such as LensCrafters and Pearle Vision in North America, OPSM and Laubman & Pank in Australasia, LensCrafters in Greater China and Sunglass Hut globally. The Group’s products are designed and manufactured in six Italy-based manufacturing plants, two wholly-owned plants in China and a sports sunglass production facility in the U.S. In 2009, Luxottica Group posted consolidated net sales of Euro 5.1 billion. Additional information about the Group is available at www.luxottica.com.
Safe Harbor Statement
Certain statements in this press release may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. Such statements involve risks, uncertainties and other factors that could cause actual results to differ materially from those which are anticipated. Such risks and uncertainties include, but are not limited to, our ability to manage the effect of the uncertain current global economic conditions on our business, our ability to successfully acquire new businesses and integrate their operations, our ability to predict future economic conditions and changes in consumer preferences, our ability to successfully introduce and market new products, our ability to maintain an efficient distribution network, our ability to achieve and manage growth, our ability to negotiate and maintain favorable license arrangements, the availability of correction alternatives to prescription eyeglasses, fluctuations in exchange rates, changes in local conditions, our ability to protect our proprietary rights, our ability to maintain our relationships with host stores, any failure of our information technology, inventory and other asset risk, credit risk on our accounts, insurance risks, changes in tax laws, as well as other political, economic and technological factors and other risks and uncertainties described in our filings with the U.S. Securities and Exchange Commission. These forward-looking statements are made as of the date hereof, and we do not assume any obligation to update them.